Cell Metab 30(5):987-996.e986
The Growing Wave of Lawsuits Thousands of individuals have filed claims against Novo Nordisk and Eli Lilly, alleging inadequate warnings about these serious risks
"Most of the time, we don't see all of your weight return, but some of it will, so we know that there will be lingering effects
A systematic review and meta-analysis of 12 randomized controlled trials (RCTs) involving 11 459 overweight or obese adults without diabetes demonstrated that GLP-1 receptor agonists significantly reduced body weight, alongside notable improvements in glycemic control, lipid levels, and blood pressure
Michael Calore: Maybe we can talk about some good news, because I know from reading your stories, that researchers are coming up with all kinds of data that's showing more positive effects of these drugs than just weight loss
When the routine feels less like discipline and more like visible progress, adherence stops being a matter of willpower